Ischemia and left ventricular dysfunction: a reciprocal relation?

There is convincing evidence that (prolonged) episodes of myocardial ischemia lead to impairment of left ventricular (LV) function and ultimately to chronic congestive heart failure (CHF), but whether the opposite is also true has not been well established. We studied this issue in two groups of CHF patients with positron emission tomography (PET) by using [13N]ammonia (13NH3) as a tracer. In the first protocol we compared 12 patients with idiopathic dilated cardiomyopathy (who have normal coronary arteries) with 12 healthy controls. In the second protocol we studied a group of 24 patients with documented coronary artery disease (CAD). In this protocol, we compared patients with normal LV function to those with LV dysfunction and CHF. In patients with cardiomyopathy, myocardial blood flow at rest was normal but flow reserve (after dipyridamole infusion) was significantly impaired (1.7 +/- 0.08) compared with normal subjects (2.7 +/- 0.04; p <0.05). Furthermore, by examining [18F]fluorodeoxyglucose (18FDG) uptake, a perfusion-metabolism mismatch was observed in 24 +/- 6% of the myocardium in patients with cardiomyopathy as opposed to 0% of normals (p <0.05). In patients with CAD, myocardial blood flow reserve (measured in non-stenotic arteries to non-infarcted area) was impaired in CHF patients (1.7 +/- 0.06) compared to those with normal LV function (2.3 +/- 0.05; p <0.05). In both groups of CHF patients, the impairment of blood flow reserve showed a significant correlation with the severity of CHF. In conclusion, myocardial blood flow reserve is impaired in patients with CHF in proportion to the degree of CHF. Metabolic studies with 18FDG further show that, in patients with idiopathic dilated cardiomyopathy and CHF, flow-metabolism mismatch is present in a substantial part of the myocardium, suggesting a pathogenetic role for ischemia.

[1]  D. V. van Veldhuisen,et al.  Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction. The Captopril and Thrombolysis Study (CATS) Investigators. , 1997, Journal of the American College of Cardiology.

[2]  C. Dunn,et al.  Carvedilol , 1997, Drugs.

[3]  G. Heusch,et al.  Characterization of hibernating and stunned myocardium. , 1994, European heart journal.

[4]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[5]  W Vaalburg,et al.  Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris. , 1996, The American journal of cardiology.

[6]  J. Pruim,et al.  Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  L. Wilkins A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.

[8]  B. D. de Smet,et al.  Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. , 1993, Cardiovascular research.

[9]  J. Elefteriades,et al.  Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. , 1993, Journal of the American College of Cardiology.

[10]  R. Alexander,et al.  The dysfunctional endothelium in heart failure. , 1993, Journal of the American College of Cardiology.

[11]  V. Dzau Autocrine and paracrine mechanisms in the pathophysiology of heart failure. , 1992, The American journal of cardiology.

[12]  D. Hayoz,et al.  Endothelial function in chronic congestive heart failure. , 1992, The American journal of cardiology.

[13]  Van Gilst,et al.  ROLE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN ANGINA-PECTORIS , 1992 .

[14]  J. Poloniecki,et al.  Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy. , 1991, The American journal of cardiology.

[15]  R D Fish,et al.  Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. , 1990, Circulation.

[16]  S. Rahimtoola,et al.  The hibernating myocardium. , 1989, American heart journal.

[17]  T. Spinks,et al.  Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. , 1986, Circulation.

[18]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[19]  R. W. Brower,et al.  Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. , 1984, Circulation.

[20]  D. Kuhl,et al.  N‐13 Ammonia as an Indicator of Myocardial Blood Flow , 1981, Circulation.